Effectiveness of 32 versus 20 weeks of prednisolone in leprosy patients with recent nerve function impairment: A randomized controlled trial

While prednisolone is commonly used to treat recent nerve function impairment (NFI) in leprosy patients, the optimal treatment duration has not yet been established. In this "Treatment of Early Neuropathy in Leprosy" (TENLEP) trial, we evaluated whether a 32-week prednisolone course is mor...

Full description

Saved in:

Bibliographic Details
Published in:	PLoS neglected tropical diseases Vol. 11; no. 10; p. e0005952
Main Authors:	Wagenaar, Inge, Post, Erik, Brandsma, Wim, Bowers, Bob, Alam, Khorshed, Shetty, Vanaja, Pai, Vivek, Husain, Sajid, Sigit Prakoeswa, Cita Rosita, Astari, Linda, Hagge, Deanna, Shah, Mahesh, Neupane, Kapil, Tamang, Krishna Bahadur, Nicholls, Peter, Richardus, Jan Hendrik
Format:	Journal Article
Language:	English
Published:	United States Public Library of Science 04.10.2017 Public Library of Science (PLoS)
Subjects:	Adolescent Adult Analysis Anti-Inflammatory Agents - administration & dosage Anti-Inflammatory Agents - therapeutic use Biology and Life Sciences Body weight Care and treatment Clinical trials Dosage and administration Double-Blind Method Drug Administration Schedule Drug therapy Duration Edema Female Hospitals Humans Impairment Laboratories Leprosy Leprosy - complications Leprosy - drug therapy Male Medicine Medicine and Health Sciences Middle Aged Nerves Nervous system diseases Neuropathy Patients Peripheral Nervous System Diseases - drug therapy Peripheral Nervous System Diseases - etiology Prednisolone Prednisolone - administration & dosage Prednisolone - therapeutic use Public health Randomization Research and Analysis Methods Skeletal muscle Supervision Testing Treatment outcome Tropical diseases Tumor necrosis factor-TNF Young Adult Bangladesh Mumbai India Nepal India
ISSN:	1935-2735, 1935-2727, 1935-2735
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!